Department of Neurosurgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Department of Hematology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2063629. doi: 10.1080/21645515.2022.2063629. Epub 2022 May 6.
We explored the willingness to pay for booster dose of COVID-19 vaccine among health-care workers in Taizhou, China.
A population-based self-administered online questionnaire evaluating the willingness of health-care workers to pay for booster vaccination of COVID-19 vaccine was conducted in Taizhou, China. Of the 1102 health-care workers received the invitation, 1072 (97.3%) had received twice vaccination of COVID-19 vaccine.
There were 1569 (53.1%) out of 1072 health-care workers not willing to pay for thebooster dose of COVID-19 vaccines, 348 (32.5%) were willing to pay less than 100CHY for the booster dose of COVID-19 vaccines, only 155 (14.5%) were willing to pay more than 100 CHY. The factors related to willingness to pay for booster dose of COVID-19 vaccines were education level (c = 9.42, P = .01) or whether they had adverse effect to COVID-19 vaccines (c = 11.87, P < .01) .
This study found that about half of health-care workers were willing to pay for booster dose of inactivated SARS-CoV-2 vaccines in Taizhou, China, most of them are willing to pay less than 100 CHY. Health-care workers' willingness to pay for booster dose of COVID-19 vaccines were related to sex, education level, whether they had adverse effect to COVID-19 vaccines.
我们探讨了中国台州医护人员对 COVID-19 疫苗加强针的支付意愿。
在中国台州，采用基于人群的自我管理在线问卷评估医护人员对 COVID-19 疫苗加强针接种的支付意愿。在收到邀请的 1102 名医护人员中，有 1072 名（97.3%）已接种了两剂 COVID-19 疫苗。
在 1072 名医护人员中，有 1569 名（53.1%）不愿意为 COVID-19 疫苗加强针付费，348 名（32.5%）愿意支付低于 100 元人民币的费用，只有 155 名（14.5%）愿意支付超过 100 元人民币。与支付 COVID-19 疫苗加强针意愿相关的因素包括教育水平（c = 9.42，P = .01）或是否对 COVID-19 疫苗有不良反应（c = 11.87，P < .01）。
本研究发现，中国台州约一半的医护人员愿意为灭活 SARS-CoV-2 疫苗接种加强针，其中大多数愿意支付低于 100 元人民币的费用。医护人员对 COVID-19 疫苗加强针的支付意愿与性别、教育水平、是否对 COVID-19 疫苗有不良反应有关。
